Objective: Efforts to increase human papillomavirus (HPV) vaccine coverage rates in
adolescents include finding ways to improve discussions between clinicians and parents …

OBJECTIVES: Although a human papillomavirus (HPV) vaccine has been available for more
than 3 years, little research has documented the uptake and predictors of vaccination among …

HPV vaccination rates remain suboptimal in the United States. While the current literature
focuses on expressly hesitant parents, few studies have examined parents with “high intent” …

Objective To assess human papillomavirus (HPV) vaccination coverage among adolescents
by provider recommendation status. Study design The 2011-2016 National Immunization …

In 2013, approximately one-third of US adolescent males age 13–17 y had received≥ 1
doses of HPV vaccines and only 14% had received≥ 3 doses. This study used a nationally …

Human papillomavirus (HPV) vaccination coverage among adolescent females is well
below national public health goals. Many known barriers to HPV vaccine receipt can be …

Purpose HPV is the most common sexually transmitted infection. The quadrivalent HPV
vaccination was approved for use in males ages 9 to 26 in 2009 and recommended for …

The success of future human papillomavirus (HPV) vaccination programs will depend on
individuals' willingness to accept vaccination, parents' willingness to have their …

Since introduction of the human papillomavirus (HPV) vaccine, there remains low uptake
compared to other adolescent vaccines. There is limited information postapproval about …

To examine health providers' perceived barriers, supports, and vaccination actions in
delivering the HPV vaccine to females ages 9–17 in four states. Differences in providers' …